Document is current
Any future updates will be listed below
-
Authors
Mozaffarian, Dariush http://orcid.org/0000-0001-7958-9492
O’Hearn, Meghan
El-Abbadi, Naglaa H.
Blumberg, Jeffrey B.
Micha, Renata
- License Information
-
More Information
Article History
Received: 30 May 2022
Accepted: 20 June 2022
First Online: 11 August 2022
Competing interests
: Outside the submitted work, N.H.E-A., J.B.B. and R.M. report a prior research grant from Danone. Outside the submitted work, D.M. reports research funding from the National Institutes of Health, the Gates Foundation, The Rockefeller Foundation, Vail Innovative Global Research and Kaiser Permanente; personal fees from Acasti Pharma, Barilla, Danone and Motif FoodWorks; scientific advisory board, Beren Therapeutics, Brightseed, Calibrate, Discern Dx, Elysium Health, Filtricine, HumanCo, January Inc., Perfect Day, Tiny Organics and (ended) Day Two and Season Health; stock ownership in Calibrate and HumanCo; and chapter royalties from UpToDate. Outside the submitted work, J.B.B. reports personal fees from Guiding Stars Licensing Company. M.O. declares no competing interests.
